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Abstract 12 
Air pollution is a widespread health problem associated with respiratory symptoms. Continuous 13 
exposure monitoring was performed to estimate alveolar and tracheobronchial dose, measured as 14 
deposited surface area, for 103 children and to evaluate the long-term effects of exposure to 15 
airborne particles through spirometry, skin prick tests and measurement of exhaled nitric oxide 16 
(eNO). The mean daily alveolar deposited surface area dose received by children was 17 
1.35×103 mm2. The lowest and highest particle number concentrations were found during sleeping 18 
and eating time. A significant negative association was found between changes in pulmonary 19 
function tests and individual dose estimates. Significant differences were found for asthmatics, 20 
children with allergic rhinitis and sensitive to allergens compared to healthy subjects for eNO. 21 
Variation is a child’s activity over time appeared to have a strong impact on respiratory outcomes, 22 
which indicates that personal monitoring is vital for assessing the expected health effects of 23 
exposure to particles. 24 
 25 
Capsule: The respiratory health effects of daily airborne particle dose on children through personal 26 
monitoring. 27 
 28 
Keywords: alveolar deposited particle surface area, exhaled nitric oxide, health respiratory effects, 29 
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1. Introduction 32 
Air pollution is a widespread public health problem associated with several adverse health 33 
outcomes ranging from premature mortality to respiratory symptoms and impaired lung function 34 
(Kreyling et al. 2006; Pope and Dockery 2006; Cesaroni et al. 2013). The adverse effects of air 35 
pollution on human cardiovascular and respiratory systems have been examined in some cohort 36 
studies (Dubnov et al. 2007; Gauderman et al. 2000; Pope et al. 2004; Samet et al. 2000). Both 37 
spirometric function and exhaled nitric oxide (eNO), a marker of airway inflammation, have been 38 
used as biomarkers of effects on the lower airway (Lee et al. 2011; Rosenlund et al. 2009; Lagorio 39 
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et al. 2006; Smith et al. 2009; Saito et al. 2004; Steerenberg et al. 1999) and have been shown to be 1 
related to exposure to oxides of nitrogen (NOx), particulate matter less than 2.5 µm in aerodynamic 2 
diameter (PM2.5) and elemental carbon in a cohort of adolescents in southern California 3 
(Gauderman et al. 2004). In that cohort, the forced expiratory volume in one second (FEV1) was 80 4 
ml less in the city with the highest PM2.5 concentration, compared with the city with the lowest 5 
PM2.5 concentration.  6 
The potential of particles to cause adverse respiratory and systemic health effects is related to 7 
their ability to enter the lungs, potentially carrying a number of toxic compounds with them. At 8 
present, it is not known which particle size, morphology or chemical components are most strongly 9 
related to the negative effects on human health and further research in this field is required. In terms 10 
of particle size, attention has shifted between mass (PM10 or PM2.5), surface area (Giechaskiel et al. 11 
2009, Buonanno et al. 2011a) and particle number concentrations (Franck et al. 2011), whose 12 
prevalent contribution is due to ultrafine particles (UFPs), with a diameter less than 100 nm. 13 
Recently, interest has focused on UFPs, due to their high deposition fraction, large surface area, 14 
chemical composition, potential to translocate to the circulation (Weichenthal 2012) and their 15 
ability to induce inflammation, penetrate into cell membranes (Unfried et al. 2007) and deposit in 16 
secondary organs (Semmler et al. 2004), including brain tissue (Calderon-Garciduenas et al. 2004). 17 
These effects have received more attention in relation to children, because they inhale a higher dose 18 
of airborne particles relative to lung size when compared with adults (Buonanno et al. 2012a; 19 
Burtscher and Schüepp 2012) and have an increased breathing frequency compared to adults 20 
(Bateson and Schwartz 2008), causing persistent alterations in distal airway architecture that are 21 
characterized by an initial decrease in airway cell proliferation (Lee et al. 2010). 22 
Nevertheless, the major difficulty facing epidemiological studies of UFPs is mostly related to the 23 
estimation of individual exposure levels. The most common current approach assumes that each 24 
person in a given region has the same exposure level, which is often obtained from a few air quality 25 
monitors and reflects the mean concentrations in the entire urban area or community. This approach 26 
could lead to significant errors in the estimation of individual exposure to air pollutants because the 27 
actual exposure is strongly related to the time-activity of the individuals (Buonanno et al. 2011b; 28 
Buonanno et al. 2012a). Furthermore, the use of mean air pollution levels smoothes peak air 29 
pollution concentrations and thus, may result in unreliable estimates of exposure (Manigrasso et al. 30 
2013). Furthermore, several authors have suggested that short term fluctuations in aerosol 31 
concentrations increase morbidity and mortality (Brugge et al. 2007; Strak et al. 2010). 32 
An additional limitation of epidemiological studies is that most of them are focused on the 33 
exposure-response, and not on the dose-response relationship and, as a matter of fact, the dose-34 
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response relationship represents the main focus of toxicological studies (Sayes et al. 2007). 1 
Therefore, in order to compare personal particle dose to such a threshold, an accurate dose 2 
evaluation (approaching as much as possible the actual exposure) needs to be carried out. This is a 3 
crucial aspect, which can only be solved through personal sampling that is able to measure particle 4 
concentrations received by people in every microenvironment they visit during a typical day, and by 5 
estimating the corresponding doses. 6 
The work reported in this paper was carried out as part of the international project titled 7 
“Ultrafine particle from traffic emission on children health (UPTECH)” (Queensland University of 8 
Technology, Brisbane, Australia), which aims to address the lack of epidemiological results on the 9 
effects of exposure to UFPs emitted by motor vehicles on children's health in schools 10 
(http://www.ilaqh.qut.edu.au/Misc/UPTECH%20Study%20Design.htm). The main aim of this 11 
paper is to focus on the individual dose-response relationship for children participating in the study. 12 
To this purpose, we estimated the daily dose of alveolar and tracheobronchial deposited surface area 13 
by measuring the daily exposure to particle number concentration for each child. A detailed study of 14 
each child's daily activity patterns was also conducted based on the Global Positioning Systems 15 
(GPS) and diaries carried by each child. In order to evaluate the children's respiratory function, 16 
pulmonary function (spirometry), skin prick and eNO tests were performed. As far as we are aware, 17 
this is the first time when a direct association between personal dose and respiratory health effects 18 
was determined. 19 
 20 
2. Materials and methods 21 
2.1 Study population 22 
This study was approved by the Administrative Board of the University of Cassino and Southern 23 
Lazio. Written informed consent was obtained from the parents of each child prior to participation 24 
in the study. The study population consisted of 103 children, aged 8-11 years, attending schools in 25 
the area of Cassino (Central Italy). The children attended three naturally ventilated public schools 26 
and the investigations were carried out from December 2010 to December 2011. One rural and two 27 
urban schools were considered: a detailed description is reported in Buonanno et al. 2013a. 28 
In addition to individual exposure measurements, a questionnaire was developed for Italian 29 
children, based on the International Study of Asthma and Allergies in Childhood (ISAAC) 30 
questionnaire, to record information on respiratory symptoms, as well as potential confounders and 31 
effect modifiers, such as housing conditions, socio-economic status and exposure to environmental 32 
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tobacco smoke (http://www.ilaqh.qut.edu.au/Misc/UPTECH%20Questionnaire.htm). A time-1 
activity diary was completed by each child, under the supervision of their parents, to record 2 
information on potential peak exposure at specific locations and we also asked parents to select the 3 
days that were most representative of their child’s usual lifestyle. Details of the individual 4 
monitoring procedure are reported in Buonanno et al. 2013a. 5 
 6 
2.2 Instrumentation and quality assurance 7 
The mobile experimental apparatus comprised of three portable UFP counters (NanoTracer, 8 
Philips) equipped with GPS tracking. This device works by diffusion charging, using an 9 
electrometer that measures particle number concentration by means of the current induced by 10 
previously charged particles collected on a filter inside a Faraday cage (Marra et al. 2010). This 11 
instrument provides a measurement of total particle number concentration in the 10-300 nm range, 12 
as well as the corresponding number-averaged particle size. Furthermore, an assessment of the 13 
deposited particle surface area per unit volume of inhaled air in some regions of the respiratory tract 14 
(particularly in the tracheobronchial and alveolar regions) can be estimated on the basis of empirical 15 
models (Marra et al. 2010). Consequently, these UFP counters can be useful in monitoring studies 16 
because they are able to estimate the dose. 17 
The counters were calibrated at the beginning of the experimental campaign, in order to allow 18 
for data quality assurance by comparison with: i) a Condensation Particle Counter (CPC, TSI Model 19 
3775) to measure particle number concentration; ii) a Nanoparticle Surface Area Monitor (NSAM, 20 
TSI Model 3550) to assess the human lung-deposited surface area of particles corresponding to 21 
tracheobronchial (TB) and alveolar (A) regions of the lung; and iii) a Scanning Mobility Particle 22 
Sizer Spectrometer (SMPS, TSI Model 3936) to measure the mean diameter of the particle number 23 
size distributions. 24 
Certified respiratory therapists performed spirometry, allergen skin prick tests and estimation of 25 
eNO in 75 children attending the three schools. 26 
Spirometry was performed in accordance with the American Thoracic Society / European 27 
Respiratory Society guidelines (Miller et al. 2005), using a computerized spirometer (Medgraphics, 28 
Cardiorespiratory Diagnostics, St. Paul, Minn, USA). Forced vital capacity (FVC), forced 29 
expiratory volume in one second (FEV1), peak expiratory flow rate (PEF or FEFMAX) and forced 30 
expiratory flow rate between 25% and 75% of FVC (FEF25-75%) were recorded. For each parameter, 31 
the highest of three measurements from acceptable maneuvers was recorded. Results were 32 
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expressed as a percentage of European Community for Steel and Coal predicted values (Quanjer et 1 
al. 1983).  2 
eNO was measured using a handheld electrochemical analyzer (NObreath®, Bedfont Scientific 3 
Ltd., Rochester, Kent, UK) that was recently evaluated Antus et al. (2010), according to the 4 
American Thoracic Society and European Respiratory Society (American Thoracic Society, 2005) 5 
guidelines. Children were asked to inhale ambient air to near total lung capacity and then exhaled 6 
for 10 s at a constant flow rate of 50 mL s-1 through a disposable mouthpiece into the device. All 7 
measurements were performed between 9:00 AM and 12:00 PM. Children did not eat or perform 8 
any strenuous physical activity during the 60 minutes prior to the tests being carried out. Three 9 
parallel readings were recorded in order to obtain measurements that were suitable for use in 10 
clinical practice (Antus et al. 2010). 11 
Skin prick tests (SPTs) were performed by allergists to assess atopic status. The test was 12 
performed according to the standardized ISAAC II protocol (Weiland et al., 2004). The following 13 
allergens were tested: dermatophagoides farinae, dermatophagoides pteronyssinus, cladosporium 14 
clarosporoides, alternaria tenuis, penicillium mix, cat dander, dog dander, cypress pollen, 15 
mixed grasses, olive, lolium perenne, wall pellitory, plantaginaceae, and German cockroach 16 
(Stallergenes, Italy). Positive and negative control solutions were also tested. A drop of each 17 
solution was placed on the skin (forearm) and the skin beneath each drop was pricked with a needle. 18 
Wheal size was measured 20-30 min later as the mean of the largest diameter and its perpendicular. 19 
Wheal sizes for allergens that were ≥ 3mm greater than the negative control were considered 20 
positive for that allergen. Children with one or more positive responses to these allergens were 21 
regarded as atopic.  22 
2.3 Methodology description 23 
In order to perform individual monitoring, each child kept the NanoTracer device for two days, 24 
carrying it with them in all of the microenvironments where he or she spent their time. The children 25 
were also asked to record their main activities, indicating the start and end times for each one. 26 
Based on these diaries, the corresponding average particle number concentration, diameter, and 27 
deposited alveolar and tracheobronchial surface area concentrations were calculated. The dose (in 28 
terms of deposited alveolar or tracheobronchial surface area, mm2) received by each child in each 29 
microenvironment/activity was determined by multiplying the alveolar and tracheobronchial surface 30 
area concentration (Sa,tb) of inhaled particles by the time spent (T) in the jth microenvironment and 31 
the inhalation rate (IRactivity) corresponding to the activity carried out (Klepeis 2006). Then, we 32 
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summed the partial doses to estimate the daily total deposited alveolar and tracheobronchial surface 1 
area (dose), ,a tbS , as reported in eq. (1). 2 
 3 
{ }, ,1
n
a tb activity a tbj j
S IR S T
=
= ⋅ ⋅∑   (1) 4 
 5 
Inhalation rates (IRactivity) for the different activities were adopted from US EPA estimates (US 6 
EPA 2004) that ranged from 0.3 m3 h-1 during sleep and resting to 1.4 m3 h-1 during sporting 7 
activities. 8 
In order to analyze the contributions of each activity/microenvironment in more depth, we 9 
calculated the “exposure intensity”, by linking the daily exposure fraction with the daily time 10 
fraction, as described in equation (2) (Wang et al. 2011): 11 
 12 
Exposure intensity = Daily exposure fraction (%) / Daily time fraction (%)  (2) 13 
 14 
Clinical tests were performed during the same period as particle exposure monitoring. 15 
 16 
2.4 Data analysis 17 
The values were expressed as means ± standard deviation. When the measurement distributions 18 
were Gaussian, differences between groups were tested by analysis of variance (ANOVA). When a 19 
significant difference between groups was observed, intergroup comparisons were made using the 20 
Student’s t test. A p value < 0.01 was considered significant. 21 
3. Results and discussion 22 
3.1 Population study characteristics 23 
Characteristics of the study population are shown in Table 1. The mean (standard deviation, SD) 24 
age of children was 10.1 (1.1) years with an approximately equal sex distribution. Over half were 25 
atopic, one third were sensitized to house dust mites and 16% reported a diagnosis of asthma. 26 
The children mainly lived in rural areas (61%), although a substantial proportion came from both 27 
urban and suburban areas (39%). A high portion of the children travelled to school by car (73%). 28 
The children travelled through urban, suburban and mixed areas, including 13% who experienced 29 
heavy traffic conditions. 30 
7 
 
The proportion of children exposed to indoor pollutant sources is shown in Table 1. All came 1 
from homes that used gas for cooking and nearly half their homes used gas for heating. Exposure to 2 
other indoor pollutant sources was common. 3 
The relative contribution of selected activities and microenvironments to the daily time-activity 4 
pattern of the children are reported in Table 1. In general, children spent 25% ± 9% (360 ± 130 min) 5 
of their total daily time at school and 65% ± 24%  (936 ± 346 min) at home, of which 5.4% was 6 
spent eating and 37% was spent sleeping. Children spent 3.1% ± 2.3% (45 ± 33 min) of their day 7 
using various modes of transportation.  8 
 9 
3.2 Estimated personal dose received by the children  10 
Table 2 shows the dose, exposure intensity and contribution of different 11 
activities/microenvironments to the daily dose of alveolar deposited surface area received by the 12 
children. The mean daily dose received by the children was 1.35×103 ± 6.1×102 mm2, which is 13 
similar to the corresponding value (1.72 × 103 mm2) determined by Buonanno et al. (2011b) for 6-14 
10 years old attending schools in Italy between 8:30 AM to 1:30 PM. 15 
A child's home was found to be the major contributor (57%) to total daily dose, while school 16 
time contributed 18%  and cooking/eating activity contributed 14% of daily exposure (182 mm2). 17 
Cooking/eating had the highest exposure intensity (greater than 3.5), which is indicative of the very 18 
high dose received per time unit during this activity.  19 
In order to investigate the effect of possible confounders, the overall population of students was 20 
separated into several distinct sub-populations according to: gender, smoking parents, presence of 21 
fireplaces at home, traffic jams during the school-home route, prevalent type of transportation (car, 22 
walking), and the location of the children's houses (Buonanno et al. 2012a). 23 
The exposure and dose received by females (1.75×103 ± 1.21×103 mm2) was higher than for 24 
males (1.07×103 ± 5.64×102 mm2), p < 0.01, and particularly high exposures were recorded for 25 
children with fireplaces at home and those that experienced traffic jams on their way to or from 26 
school (greater than 45% and 41% in respect to the mean value, respectively, p < 0.01). Finally, the 27 
location of the children's houses was also relevant, with children living in urban areas exposed to 28 
particle concentrations approximately 25% higher than the overall mean value (p < 0.01). 29 
 30 
3.3 Respiratory health outcomes 31 
Respiratory health outcomes are shown in Table 3.  32 
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Fig. 1 shows the spirometry outcomes for all children versus daily alveolar deposited surface 1 
area dose. Based on the R2 values, an increase in daily alveolar deposited surface area dose was not 2 
related to FEFmax, while moderate and strong associations were found for FEV1 and FEF25-75, 3 
respectively. In particular, an increase in dose of 100 mm2 resulted in a 0.8% decrease in FEF25-75.  4 
With regard to eNO, a mean value of 10.8 ± 9.2 ppb was observed for healthy subjects. This 5 
value was similar to that found in a previous study carried out for 522 children aged 8-11 years 6 
living in three European (Denmark, The Netherlands and Italy) and two US cities (Buchvald et al. 7 
2005). In particular, a very good metrological compatibility (0.1) was observed, in terms of 8 
normalized error En and standard uncertainty U (where 1 and 2 represent the two data series), based 9 
on the following equation (ISO/IEC Guide 43–1 1997): 10 
 11 
1 2
2 2
1 2
n
eNO eNO
E
U U
−
=
+
  (3) 12 
 13 
We did not find significant differences in either spirometric measures or eNO values between 14 
males and females or, in particular, between urban and rural schools. Consequently, the health 15 
outcomes of Italian children attending schools in the absence of indoor sources are not influenced 16 
by dose received in the school microenvironment. Therefore, in the case of monitoring studies, this 17 
microenvironment cannot be used to capture the overall exposure of children.  18 
Fig. 2 shows that eNO was correlated with daily alveolar deposited surface area dose in children 19 
with asthma and HDM allergic children without asthma but not in non-HDM allergic children 20 
without asthma.  21 
In terms of asthmatic children, an increase of 100 mm2 in daily alveolar deposited surface area 22 
dose led to an increase in eNO of 4.1 ± 0.6 ppb (correlation coefficient, R2 = 0.90).  23 
Spirometric function did not differ between healthy children and those with allergic rhinitis 24 
(mean FEF25-75 114 % vs. 102%, respectively; p < 0.5). However, eNO values were higher in 25 
children with allergic rhinitis than in healthy children (35 ppb vs 14 ppb respectively; p < 0.01). A 26 
variation of 100 mm2 in the daily alveolar deposited surface area dose for children with allergic 27 
rhinitis resulted in a 1.9 ± 0.2 ppb increase in eNO (correlation coefficient, R2 = 0.23). 28 
eNO levels were higher in HDM allergic children than those who were not allergic to HDM 29 
(47 ppb vs 14 ppb; p < 0.0002), with an increase of 100 mm2 in the daily alveolar deposited surface 30 
area dose resulting in a 3.5 ± 0.1 ppb increase in eNO (correlation coefficient, R2 = 0.51). eNO 31 
levels were also higher in those who were allergic to any allergen compared to those who were non-32 
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allergic (40 ppb vs 14 ppb, respectively; p < 0.0015). In this group, a 100 mm2 increase in the daily 1 
alveolar deposited surface area dose was associated with a 1.5 ppb increase in eNO (R2 = 0.12). 2 
Finally, as shown in Fig. 2, the effect of daily dose on eNO for healthy children was found to be 3 
negligible, with an increase of 100 mm2 in daily dose only increasing eNO by 0.15 ppb. 4 
 5 
4. Conclusions 6 
This study demonstrates the importance using personal measurements, rather than central site 7 
data, for assessing particulate exposure in studies assessing the impact of interventions designed to 8 
reduce the impact of pollution sources on children. 9 
 10 
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Table 1 – Characterization of the children population in terms of exposure and preexisting 
respiratory disorders (n = 103). 
Population characteristics (%) 
Sex: boys/girls 54/46 
Living in urban/rural/suburban area 29/61/10 
Going to school by car/ bus/walk 73/18/9.0 
Route: urban/suburban/mixed 25/40/35 
Route: highly trafficked street 13 
Exposure to second-hand tobacco smoke 9.1 
Living in damp home 37 
Pets at home 29 
Parental education high/medium/low 32/60/8 
Cooking: gas/electric stove 100/0 
Heating: gas heater/fireplace/both 17/46/37 
Living in other home (>50 days/year) 12 
Daily activity patterns (% of daily time)  
School (indoor) 25. ± 9.1 
Cooking/eating (indoor home) 
Sleeping (indoor home) 
5.4 ± 3.4 
37 ± 7.4 
Recreational time (indoor home) 23 ± 13 
Recreational time (indoor) 4.4 ± 3.0 
Outdoor 
Transportation 
2.2 ± 1.1 
3.1 ± 2.3 
Allergic rhinitis 14 
House dust mite allergic 32 
Allergic to one or more allergens (atopic) 
Asthma 
56 
16 
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Table 2 – Dose, exposure intensity and contribution of different activities/microenvironments to the 
daily dose of alveolar deposited surface area. 
Microenvironment or 
activity 
Alveolar deposited 
surface area dose 
(mm2) 
Exposure 
Intensity 
Daily dose 
fraction (%) 
School 2.4×102 ± 0.79×102 0.8 18% 
Indoor (home) 3.4×102 ± 2.5×102 1.2 25% 
Indoor (other) 1.5×102 ± 1.3×102 1.0 10% 
Sleeping 2.5×102 ± 1.1×102 0.6 19% 
Cooking/Eating 1.8×102 ± 1.7×102 3.6 14% 
Transportation 0.70×102 ± 0.56×102 1.4 5.6% 
Outdoor 1.3×102 ± 1.2×102 1.2 9.4% 
Daily dose 13×102 ± 6.1×102   
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Table 3 – Respiratory health outcomes and their relation to alveolar deposited surface area dose. 
Lung function Mean value in the 
population 
(% predicted) 
Effect of alveolar deposited surface 
area dose (% mm-2) 
t-test on the slope 
(Fig.1) 
FEFMAX 97 ± 19 -0.00049 ± 0.0022 p = 0.4 
FEV1 103 ± 10 -0.0025 ± 0.0012 p = 0.02 
FEF25-75 113 ± 23 -0.0075 ± 0.0026 p = 0.004 
eNO (ppb) 16 ± 18*   
* geometric mean 
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Figure Captions 
 
Fig. 1 – Spirometry outcomes for children versus daily alveolar deposited surface area dose. 
Figure 1a 
 
Figure 1b 
 
 
 
Figure 1c 
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Fig. 2 - eNO by alveolar deposited surface area dose in children classified as “asthma”, “no asthma 
but HDM allergic”, “no asthma – not HDM allergic”  
 
